GlaxoSmithKline PLC Director/PDMR Shareholding (1760I)
April 12 2022 - 12:10PM
UK Regulatory
TIDMGSK
RNS Number : 1760I
GlaxoSmithKline PLC
12 April 2022
GlaxoSmithKline plc (the ' Company ')
Transaction notification
1. Details of PDMR/person closely associated with them
('PCA')
==== ========================================================================================
a) Name Ms E Walmsley
==== ===================================== =================================================
b) Position/status Chief Executive Officer
==== ===================================== =================================================
c) Initial notification/ Initial notification
amendment
==== ===================================== =================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ========================================================================================
a) Name GlaxoSmithKline plc
==== ===================================== =================================================
b) LEI 5493000HZTVUYLO1D793
==== ===================================== =================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ========================================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument
ISIN: GB0009252882
==== ===================================== =================================================
b) Nature of the Acquisition of Ordinary Shares following
transaction the re-investment of dividends paid to
shareholders on 7 April 2022, on shares
held through the Company's Share Reward
Plan.
==== ===================================== =================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ===================================== ========================= ===================
GBP 17.3554 32
==================================================================== ===================
d) Aggregated information N/A (single transaction)
====
Aggregated volume
Price
================================================================= ==========================
e) Date of the transaction 2022-04-07
==== ===================================== =================================================
f) Place of the London Stock Exchange (XLON)
transaction
==== ===================================== =================================================
1. Details of PDMR/person closely associated with them
('PCA')
==== ========================================================================================
a) Name Mr R Connor
==== ===================================== =================================================
b) Position/status President, Vaccines and Global Health
==== ===================================== =================================================
c) Initial notification/ Initial notification
amendment
==== ===================================== =================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ========================================================================================
a) Name GlaxoSmithKline plc
==== ===================================== =================================================
b) LEI 5493000HZTVUYLO1D793
==== ===================================== =================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ========================================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument
ISIN: GB0009252882
==== ===================================== =================================================
b) Nature of the Acquisition of Ordinary Shares following
transaction the re-investment of dividends paid to
shareholders on 7 April 2022, on shares
held through the Company's Share Reward
Plan.
==== ===================================== =================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ===================================== ========================= ===================
GBP 17.3554 91
==================================================================== ===================
d) Aggregated information N/A (single transaction)
====
Aggregated volume
Price
================================================================= ==========================
e) Date of the transaction 2022-04-07
==== ===================================== =================================================
f) Place of the London Stock Exchange (XLON)
transaction
==== ===================================== =================================================
1. Details of PDMR/person closely associated with them
('PCA')
==== ========================================================================================
a) Name Ms D Conrad
==== ===================================== =================================================
b) Position/status Chief People Officer
==== ===================================== =================================================
c) Initial notification/ Initial notification
amendment
==== ===================================== =================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ========================================================================================
a) Name GlaxoSmithKline plc
==== ===================================== =================================================
b) LEI 5493000HZTVUYLO1D793
==== ===================================== =================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ========================================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument
ISIN: GB0009252882
==== ===================================== =================================================
b) Nature of the Acquisition of Ordinary Shares following
transaction the re-investment of dividends paid to
shareholders on 7 April 2022, on shares
held through the Company's Share Reward
Plan.
==== ===================================== =================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ===================================== ========================= ===================
GBP 17.3554 6
==================================================================== ===================
d) Aggregated information N/A (single transaction)
====
Aggregated volume
Price
================================================================= ==========================
e) Date of the transaction 2022-04-07
==== ===================================== =================================================
f) Place of the London Stock Exchange (XLON)
transaction
==== ===================================== =================================================
1. Details of PDMR/person closely associated with them
('PCA')
==== =========================================================================================
a) Name Mr J Ford
==== ====================================== =================================================
b) Position/status SVP and Group General Counsel, Legal and
Compliance
==== ====================================== =================================================
c) Initial notification/ Initial notification
amendment
==== ====================================== =================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== =========================================================================================
a) Name GlaxoSmithKline plc
==== ====================================== =================================================
b) LEI 5493000HZTVUYLO1D793
==== ====================================== =================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== =========================================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument
ISIN: GB0009252882
==== ====================================== =================================================
b) Nature of the Acquisition of Ordinary Shares following
transaction the re-investment of dividends paid to
shareholders on 7 April 2022, on shares
held through the Company's Share Reward
Plan.
==== ====================================== =================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ====================================== ========================= ===================
GBP17.3554 5
===================================================================== ===================
d) Aggregated information N/A (single transaction)
====
Aggregated volume
Price
================================================================== ==========================
e) Date of the transaction 2022-04-07
==== ====================================== =================================================
f) Place of the London Stock Exchange (XLON)
transaction
==== ====================================== =================================================
1. Details of PDMR/person closely associated with them
('PCA')
==== ========================================================================================
a) Name Ms S Jackson
==== ===================================== =================================================
b) Position/status SVP, Global Communications and CEO Office
==== ===================================== =================================================
c) Initial notification/ Initial notification
amendment
==== ===================================== =================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ========================================================================================
a) Name GlaxoSmithKline plc
==== ===================================== =================================================
b) LEI 5493000HZTVUYLO1D793
==== ===================================== =================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ========================================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument
ISIN: GB0009252882
==== ===================================== =================================================
b) Nature of the Acquisition of Ordinary Shares following
transaction the re-investment of dividends paid to
shareholders on 7 April 2022, on shares
held through the Company's Share Reward
Plan.
==== ===================================== =================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ===================================== ========================= ===================
GBP 17.3554 84
==================================================================== ===================
d) Aggregated information N/A (single transaction)
====
Aggregated volume
Price
================================================================= ==========================
e) Date of the transaction 2022-04-07
==== ===================================== =================================================
f) Place of the London Stock Exchange (XLON)
transaction
==== ===================================== =================================================
1. Details of PDMR/person closely associated with them
('PCA')
==== ============================================================================================
a) Name Mr D Jackson
==== ===================================== =====================================================
b) Position/status PCA of Ms S Jackson (SVP, Global Communications
and CEO Office)
==== ===================================== =====================================================
c) Initial notification/ Initial notification
amendment
==== ===================================== =====================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ============================================================================================
a) Name GlaxoSmithKline plc
==== ===================================== =====================================================
b) LEI 5493000HZTVUYLO1D793
==== ===================================== =====================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ============================================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument
ISIN: GB0009252882
==== ===================================== =====================================================
b) Nature of the Acquisition of Ordinary Shares following
transaction the re-investment of dividends paid to
shareholders on 7 April 2022, on shares
held through the Company's Share Reward
Plan.
==== ===================================== =====================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ===================================== =========================== =====================
GBP 17.3554 33
====================================================================== =====================
d) Aggregated information N/A (single transaction)
====
Aggregated volume
Price
=================================================================== ============================
e) Date of the transaction 2022-04-07
==== ===================================== =====================================================
f) Place of the London Stock Exchange (XLON)
transaction
==== ===================================== =====================================================
1. Details of PDMR/person closely associated with them
('PCA')
==== ========================================================================================
a) Name Mr L Miels
==== ===================================== =================================================
b) Position/status Chief Commercial Officer
==== ===================================== =================================================
c) Initial notification/ Initial notification
amendment
==== ===================================== =================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ========================================================================================
a) Name GlaxoSmithKline plc
==== ===================================== =================================================
b) LEI 5493000HZTVUYLO1D793
==== ===================================== =================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ========================================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument
ISIN: GB0009252882
==== ===================================== =================================================
b) Nature of the Acquisition of Ordinary Shares following
transaction the re-investment of dividends paid to
shareholders on 7 April 2022, on shares
held through the Company's Share Reward
Plan.
==== ===================================== =================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ===================================== ========================= ===================
GBP 17.3554 4
==================================================================== ===================
d) Aggregated information N/A (single transaction)
====
Aggregated volume
Price
================================================================= ==========================
e) Date of the transaction 2022-04-07
==== ===================================== =================================================
f) Place of the London Stock Exchange (XLON)
transaction
==== ===================================== =================================================
1. Details of PDMR/person closely associated with them
('PCA')
==== ========================================================================================
a) Name Mr D Redfern
==== ===================================== =================================================
b) Position/status Chief Strategy Officer
==== ===================================== =================================================
c) Initial notification/ Initial notification
amendment
==== ===================================== =================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ========================================================================================
a) Name GlaxoSmithKline plc
==== ===================================== =================================================
b) LEI 5493000HZTVUYLO1D793
==== ===================================== =================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ========================================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument
ISIN: GB0009252882
==== ===================================== =================================================
b) Nature of the Acquisition of Ordinary Shares following
transaction the re-investment of dividends paid to
shareholders on 7 April 2022, on shares
held through the Company's Share Reward
Plan.
==== ===================================== =================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ===================================== ========================= ===================
GBP 17.3554 101
==================================================================== ===================
d) Aggregated information N/A (single transaction)
====
Aggregated volume
Price
================================================================= ==========================
e) Date of the transaction 2022-04-07
==== ===================================== =================================================
f) Place of the London Stock Exchange (XLON)
transaction
==== ===================================== =================================================
1. Details of PDMR/person closely associated with them
('PCA')
==== ========================================================================================
a) Name Mr R Simard
==== ===================================== =================================================
b) Position/status President, Pharmaceuticals Supply Chain
==== ===================================== =================================================
c) Initial notification/ Initial notification
amendment
==== ===================================== =================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ========================================================================================
a) Name GlaxoSmithKline plc
==== ===================================== =================================================
b) LEI 5493000HZTVUYLO1D793
==== ===================================== =================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ========================================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument
ISIN: GB0009252882
==== ===================================== =================================================
b) Nature of the Acquisition of Ordinary Shares following
transaction the re-investment of dividends paid to
shareholders on 7 April 2022, on shares
held through the Company's Share Reward
Plan.
==== ===================================== =================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ===================================== ========================= ===================
GBP 17.3554 33
==================================================================== ===================
d) Aggregated information N/A (single transaction)
====
Aggregated volume
Price
================================================================= ==========================
e) Date of the transaction 2022-04-07
==== ===================================== =================================================
f) Place of the London Stock Exchange (XLON)
transaction
==== ===================================== =================================================
1. Details of PDMR/person closely associated with them
('PCA')
==== ========================================================================================
a) Name Mr P Thomson
==== ===================================== =================================================
b) Position/status President, Global Affairs
==== ===================================== =================================================
c) Initial notification/ Initial notification
amendment
==== ===================================== =================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ========================================================================================
a) Name GlaxoSmithKline plc
==== ===================================== =================================================
b) LEI 5493000HZTVUYLO1D793
==== ===================================== =================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ========================================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument
ISIN: GB0009252882
==== ===================================== =================================================
b) Nature of the Acquisition of Ordinary Shares following
transaction the re-investment of dividends paid to
shareholders on 7 April 2022, on shares
held through the Company's Share Reward
Plan.
==== ===================================== =================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ===================================== ========================= ===================
GBP 17.3554 61
==================================================================== ===================
d) Aggregated information N/A (single transaction)
====
Aggregated volume
Price
================================================================= ==========================
e) Date of the transaction 2022-04-07
==== ===================================== =================================================
f) Place of the London Stock Exchange (XLON)
transaction
==== ===================================== =================================================
1. Details of PDMR/person closely associated with them
('PCA')
==== ========================================================================================
a) Name Ms D Waterhouse
==== ===================================== =================================================
b) Position/status CEO, ViiV Healthcare
==== ===================================== =================================================
c) Initial notification/ Initial notification
amendment
==== ===================================== =================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ========================================================================================
a) Name GlaxoSmithKline plc
==== ===================================== =================================================
b) LEI 5493000HZTVUYLO1D793
==== ===================================== =================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ========================================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument
ISIN: GB0009252882
==== ===================================== =================================================
b) Nature of the Acquisition of Ordinary Shares following
transaction the re-investment of dividends paid to
shareholders on 7 April 2022, on shares
held through the Company's Share Reward
Plan.
==== ===================================== =================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ===================================== ========================= ===================
GBP 17.3554 82
==================================================================== ===================
d) Aggregated information N/A (single transaction)
====
Aggregated volume
Price
================================================================= ==========================
e) Date of the transaction 2022-04-07
==== ===================================== =================================================
f) Place of the London Stock Exchange (XLON)
transaction
==== ===================================== =================================================
1. Details of PDMR/person closely associated with them
('PCA')
==== ========================================================================================
a) Name Ms V Whyte
==== ===================================== =================================================
b) Position/status Company Secretary
==== ===================================== =================================================
c) Initial notification/ Initial notification
amendment
==== ===================================== =================================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
==== ========================================================================================
a) Name GlaxoSmithKline plc
==== ===================================== =================================================
b) LEI 5493000HZTVUYLO1D793
==== ===================================== =================================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
==== ========================================================================================
a) Description of Ordinary shares of 25 pence each ('Ordinary
the financial Shares')
instrument
ISIN: GB0009252882
==== ===================================== =================================================
b) Nature of the Acquisition of Ordinary Shares following
transaction the re-investment of dividends paid to
shareholders on 7 April 2022, on shares
held through the Company's Share Reward
Plan.
==== ===================================== =================================================
c) Price(s) and Price(s) Volume(s)
volume(s)
==== ===================================== ========================= ===================
GBP 17.3554 75
==================================================================== ===================
d) Aggregated information N/A (single transaction)
====
Aggregated volume
Price
================================================================= ==========================
e) Date of the transaction 2022-04-07
==== ===================================== =================================================
f) Place of the London Stock Exchange (XLON)
transaction
==== ===================================== =================================================
, the news service of the London Stock Exchange. RNS is approved by
the Financial Conduct Authority to act as a Primary Information
Provider in the United Kingdom. Terms and conditions relating to
the use and distribution of this information may apply. For further
information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
DSHQLLFFLZLBBBD
(END) Dow Jones Newswires
April 12, 2022 12:10 ET (16:10 GMT)
Gsk (LSE:GSK)
Historical Stock Chart
From Mar 2024 to Apr 2024
Gsk (LSE:GSK)
Historical Stock Chart
From Apr 2023 to Apr 2024
